Trial intelligence / Profile preview

OAZE study of antidepressant continuation versus discontinuation during pregnancy

NL-OMON22370Active, not recruiting

Sponsor
University Medical Center Utrecht
Start
Jul 2003
Countries
1
01

Overview

Open-label trial in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Fetal movement and development, Neonatal withdrawal symptoms and 6 more. Started Jul 2003; status: active, not recruiting.

02

Conditions

major depressive disorder (MDD)anxiety disorder

Beyond the preview

Go deeper on NL-OMON22370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call